ANNA POWELL: Open Payments
NPI 1336377423 · CLEVELAND, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$782 in 41 payments from 13 companies in 2025. Trend: 2023 $634 · 2024 $505 · 2025 $782
Food & beverage: $782
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 20 | $320 |
| KVK-Tech, Inc. | 1 | $116 |
| ABBVIE INC. | 3 | $54 |
| Amgen Inc. | 3 | $46 |
| Lilly USA, LLC | 2 | $44 |
| PFIZER INC. | 2 | $39 |
| Exact Sciences Corporation | 2 | $33 |
| Currax Pharmaceuticals LLC | 2 | $33 |
| Rhythm Pharmaceuticals, Inc. | 1 | $27 |
| Philips North America LLC | 1 | $25 |
Products named: Wegovy, Ozempic, OTEZLA, ELIQUIS, Cologuard Collection Kit, CONTRAVE, VRAYLAR, IMCIVREE.
Industry payments across GA — which companies pay providers there.
